Tech Company Financing Transactions
Resolve Biosciences Funding Round
Patient Square Capital, Alafi Capital and Edbi participated in a $71 million Series B funding round for Resolve Biosciences. The round was announced on 10/24/2022.
Transaction Overview
Company Name
Announced On
10/24/2022
Transaction Type
Venture Equity
Amount
$71,000,000
Round
Series B
Investors
Proceeds Purpose
The company, which has now raised more than $100m, intends to use the funds to scale operations and accelerate product development to meet demand worldwide.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2890 Zanker Rd 102
San Jose, CA 95134
USA
San Jose, CA 95134
USA
Phone
Website
Email Address
Overview
We are bringing the latest advances in German precision engineering to the biotechnology field. Together with our talented team of scientists and investors, we are poised to lead the next generation of single-cell analysis and enable scientists around the world to apply the power of Molecular Cartography to gain new insights based on the highest-resolution view of single-cell spatial biology. Resolve Biosciences is privately held and headquartered in Monheim am Rhein, Germany.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jason Gammack
Chief Financial Officer
Erik Wiberg
Chief Technical Officer
Frank Zhong
Co-Founder
Peer Schatz
Browse more venture capital transactions:
Prev: 10/24/2022: Keebo venture capital transaction
Next: 10/24/2022: ShipIn Systems venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on tech company VC transactions. VC transactions reported here are derived from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs